COCHW — Envoy Medical, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1840877 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 39,000 -274,000 -5,959,000 -4,351,000 29,822,000 25,251,000 19,270,000
Dec 2025 75,000 -136,000 -6,385,000 -6,586,000 8,558,000 3,739,000 20,325,000
Sep 2025 42,000 -161,000 -5,708,000 -6,482,000 8,181,000 3,556,000 15,712,000
Jun 2025 78,000 -156,000 -5,070,000 -5,690,000 9,900,000 5,287,000 39,759,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-18,201,000
Investing CF
$-179,000
Financing CF
$16,633,000
CapEx
$-794,000
Dividends Paid
$-1,819,000
Buybacks
EPS Diluted TTM
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-313,396,000
Inventory
$1,546,000
Receivables
$53,000
ST Investments
EBIT TTM
$-22,166,000
Pretax Income TTM
$-23,756,000
Interest Exp TTM
$1,590,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$234,000
EBITDA
$-22,618,000
Free Cash Flow
$-7,911,875
Enterprise Value
Total Cash
$25,251,000
Total Debt
$889,000
Shares Out
Trailing EPS
Book Value
$0.14
ROE
ROA
-71.3%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 241,000 -22,270,000 -23,756,000 8,558,000 20,325,000 -18,201,000
Dec 2024 225,000 -19,256,000 -20,795,000 11,538,000 30,380,000 -17,949,000
Dec 2023 316,000 -18,359,000 -29,922,000 8,271,000 10,047,000 -17,091,000
Dec 2022 237,000 -8,706,000 -15,923,000 2,556,000 38,751,000 -8,805,000

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $154.64B $436.64
SYK STRYKER CORP $119.99B $313.00
MDT Medtronic plc $99.63B $77.60
BSX BOSTON SCIENTIFIC CORP $85.67B $57.64
MMM 3M CO $80.34B $154.03

News headlines (Yahoo Finance, 1h cache)

Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
2026-05-20 12:30 · Yahoo
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
2026-05-11 12:00 · Yahoo
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
2026-04-28 12:30 · Yahoo
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
2026-04-22 12:00 · Yahoo
Envoy Medical Appoints Chas McKhann to Board of Directors
2026-04-16 12:00 · Yahoo
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
2026-04-01 12:00 · Yahoo
Envoy Medical Reports Full Year 2025 Financial Results
2026-03-23 12:30 · Yahoo
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
2026-02-24 13:00 · Yahoo
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
2026-02-23 13:00 · Yahoo
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
2026-02-19 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.